Literature DB >> 21355731

Specificity of a canine pancreas-specific lipase assay for diagnosing pancreatitis in dogs without clinical or histologic evidence of the disease.

Shannon C Neilson-Carley1, Jane E Robertson, Shelley J Newman, David Kutchmarick, Roberta Relford, Kristen Woosley, Jörg M Steiner.   

Abstract

OBJECTIVE: To evaluate the specificity of a canine pancreas-specific lipase (cPSL) assay for diagnosing pancreatitis in dogs without clinical or histologic evidence of the disease. ANIMALS: 20 dogs from another study with macroscopic evidence of pancreatitis and 44 dogs surrendered for euthanasia or expected to die. PROCEDURES: Prior to death, physical examination of each dog was performed and blood samples were collected for serum biochemical, serum cPSL, and hematologic analyses. After death, the pancreas was removed, sectioned in 1- to 2-cm slices, and evaluated by a pathologist. Dogs were classified by whether they had clinical or macroscopic pancreatitis. Each pancreatic section was histologically examined, and mean cumulative scores (MCSs) were assigned for 8 histologic characteristics. For each characteristic, comparisons were made between dogs with and without pancreatitis to establish histologic criteria for lack of evidence of pancreatitis.
RESULTS: For all histologic characteristics except lymphocytic infiltration, the median MCS differed significantly between dogs with and without pancreatitis. Dogs were categorized as having no histologic evidence of pancreatitis when the MCSs for neutrophilic infiltration, pancreatic necrosis, peripancreatic fat necrosis, and edema were 0.0. On the basis of these criteria, 40 dogs were classified as having no evidence of pancreatitis. The cPSL concentration was within reference limits in 38 of these 40 dogs and was less than the cutoff value for diagnosing pancreatitis (400 μg/L) in 39 of the 40 dogs, resulting in a specificity of 97.5% (95% confidence interval, 86.8% to 99.9%). CONCLUSIONS AND CLINICAL RELEVANCE: The cutoff cPSL value used in this study may be useful for diagnosing pancreatitis in dogs with a lack of histologic lesions consistent with pancreatitis and for which pancreatitis is not considered a major differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355731     DOI: 10.2460/ajvr.72.3.302

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  12 in total

1.  Response to letter regarding "ACVIM consensus statement on pancreatitis in cats".

Authors:  Marnin A Forman; Joerg M Steiner; P Jane Armstrong; Melinda S Camus; Lorrie Gaschen; Steve L Hill; Caroline S Mansfield; Katja Steiger
Journal:  J Vet Intern Med       Date:  2021-05-21       Impact factor: 3.175

2.  Canine pancreatic-specific lipase concentrations in clinically healthy dogs and dogs with naturally occurring hyperadrenocorticism.

Authors:  D I Mawby; J C Whittemore; K A Fecteau
Journal:  J Vet Intern Med       Date:  2014-06-05       Impact factor: 3.333

3.  Evaluation of SNAP cPL, Spec cPL, VetScan cPL Rapid Test, and Precision PSL Assays for the Diagnosis of Clinical Pancreatitis in Dogs.

Authors:  H Cridge; A G MacLeod; G E Pachtinger; A J Mackin; A M Sullivant; J M Thomason; T M Archer; K V Lunsford; K Rosenthal; R W Wills
Journal:  J Vet Intern Med       Date:  2018-02-09       Impact factor: 3.333

4.  Hyperlipasemia in critically ill dogs with and without acute pancreatitis: Prevalence, underlying diseases, predictors, and outcome.

Authors:  Julia K Prümmer; Judith Howard; Lisa M Grandt; Rafael Obrador de Aguilar; Felix Meneses; Laureen M Peters
Journal:  J Vet Intern Med       Date:  2020-09-18       Impact factor: 3.333

5.  Evaluation of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) and 1,2-diglyceride lipase assays in dogs with naturally occurring hypercortisolism.

Authors:  Guido Linari; Francesco Dondi; Sofia Segatore; Kateryna Vasylyeva; Nikolina Linta; Marco Pietra; Rodolfo O Leal; Federico Fracassi
Journal:  J Vet Diagn Invest       Date:  2021-06-02       Impact factor: 1.569

6.  Agreement of serum Spec cPL with the 1,2-o-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester (DGGR) lipase assay and with pancreatic ultrasonography in dogs with suspected pancreatitis.

Authors:  P H Kook; N Kohler; S Hartnack; B Riond; C E Reusch
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

7.  Prognostic value of canine pancreatic lipase immunoreactivity and lipase activity in dogs with gastric dilatation-volvulus.

Authors:  Giuseppe Spinella; Francesco Dondi; Lisa Grassato; Luca Magna; Veronica Cola; Massimo Giunti; Sara Del Magno; Simona Valentini
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

8.  Serum canine pancreatic-specific lipase concentrations in dogs with naturally occurring Babesia rossi infection.

Authors:  Liza S Köster; Jörg M Steiner; Jan S Suchodolski; Johan P Schoeman
Journal:  J S Afr Vet Assoc       Date:  2015-08-13       Impact factor: 1.474

9.  Comparative repeatability of pancreatic lipase assays in the commercial and in-house laboratory environments.

Authors:  Harry Cridge; Andrew J Mackin; Jonathan A Lidbury; Jan S Suchodolski; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2020-04-06       Impact factor: 3.333

10.  Effect of prednisolone therapy on serum levels of 1,2-O-dilauryl-rac-glycero glutaric acid-(6'-methylresorufin) ester lipase in dogs.

Authors:  Beatriz Mendoza; Maria Joana Dias; Telmo Nunes; Maria Alexandra Basso; Juan Hernandez; Rodolfo Oliveira Leal
Journal:  J Vet Intern Med       Date:  2020-11-04       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.